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Background: Clinical studies have demonstrated that HPV induced tumors constitute a specific subclass of cancer
with a better response to radiation treatment. The purpose of this study was to investigate meaning of viral
E2-gene for radiosensitivity.
Methods: W12 cells contain episomal HPV 16 genomes, whereas S12 cells, which derive from the W12 line, contain
HPV DNA as integrated copies. Clonogenic survival was analyzed using 96-well in vitro test. Using flow cytometry
cell cycle analyses were performed. Expression of pRb and p53 were analyzed using intracellular staining.
Results: W12 cells (intact E2 gene) showed a lower survival fraction than S12 cells. W12 cells developed a G2/M
block 24 h after irradiation with 2 Gy whereas S12 showed no G2/M bloc. After irradiation S12 cells developed
polyploidy and pRb-positive cells decreased. W12 cells showed no change of pRb-positive cells.
Conclusions: Depending on E2 gene status differences in cell cycle regulation might cause radioresistance. The
E2/E7/pRb pathway seems to influence HPV-induced radiosensitivity. Our experiments demonstrated an effect of
HPV on radiosensitivity of cervical keratinocytes via viral transcription regulator E2 pathway.
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Cervical cancer is considered to be a sexually transmitted
disease and has been correlated with Human Papilloma-
virus infection (HPV) [1]. Besides a number of prognostic
factors like depth of stromal invasion, tumor differenti-
ation or nodal involvement, presence of Human Papillo-
mavirus has been suggested an important marker of
disease severity in cervical cancer [2]. The viral genome
is organized into three general segments of unequal size:
long control region (LCR), early (E) and late (L) genes.
Acting as transcriptional activator or repressor, E2 pro-
tein regulates virus transcription and genome replication
[3]. Loss of E2 gene integrity seems to play a role for
outcome and local control in cervical carcinomas [4,5].
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reproduction in any medium, provided the ormanipulate cell cycle and ability of apoptosis [6]. There
may be a possible correlation between radiotherapy, E2
function and outcome [4,7,8]. The E6 oncoprotein can
form a complex with host cell p53 tumor suppressor
protein and inducing p53 degradation and overcoming
G1/S checkpoint control in DNA-damaged cells [9]. E7
oncoprotein binds to hypophosphorylated pRb form re-
sulting in its degradation and inappropriate release of
E2F transcription factor [10]. Pre-clinical data arising
from comparison between non-HPV-tumor cells and
their counterparts transfected with sequences of HPV
genome should be interpreted with caution because arti-
ficial induced expression might not mirror in vivo reality.
To avoid artificial uncertainties we used W12/S12 cell
model derived from a low grade cervical lesion by Stanley
MA et al. 1989[11] to evaluate the influence of E2 on in-
trinsic radiosensitivity of cervical cells to support the hy-
pothesis of E2-gene status as a predictive marker for
therapeutic outcome in cervical cancer patients.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Cell lines and cell culture
W12 cell line was derived from a low grade cervical le-
sion by Stanley MA et al. 1989, and is unique among
HPV16-containing cell lines in carrying its HPV 16 gen-
ome as a multicopy episome [11]. We made use of a pair
of isogenic cell lines, W12 and S12 to compare differ-
ence of survival after irradiation. W12 cells contain
episomal HPV 16 genomes, whereas S12 cells, which de-
rived from the W12 line, contain HPV DNA as integrated
copies [12].
W12 cells were cultured with lethally irradiated Swiss
3T3 feeder cells and in medium consisting a mix of one-
quarter Dulbecco’s modified eagle’s medium (Gibco) and
three-quarters Ham F-12 medium (Gibco) containing 5%
fetal calf serum, penicillin, streptomycin, an supplements
(all from Sigma) as follows: 8.4.ng of cholera toxin/ml,
5 μg of insulin/ml, 24.3μg of adenine/ml, 0.5 μg of hy-
drocortisone/ml and 10 ng of epithelial growth factor
per ml. Cells were split when reached 80% confluence.
S12 cells were obtained by collecting surviving W12 cells
cultured without feeder layer support.
E2-gene specific PCR
HPV16-positive cells were tested for an intact E2 gene
in three separate amplification reactions which allows
amplifying three amplicons of different length determin-
ing integrity of E2-gene [8]. The procedure and primer
sequences used were as described in the same reference.
Clonogenic growth assay and irradiation
Clonogenic survival was analyzed by using 96-well
in vitro test as followed: 1-100 cells per well were seed.
The plates were examined with an inverted phase con-
trast microscope at intervals of 7, 10, 14 days. A well
was considered positive when a colony in it reached a
size of 50 cells or more. Cells were fixed with 70% for
ten minutes prior staining with 0.1% methylene–blue.
After staining weels were washed with destilled water.
Plating efficiency (PE) was calculated using poisson sta-
tistics according to formula PE = -ln (neg wells/total
wells)/ number of cells plated per well [13]. In radiation
experiments fraction of survival was determined by div-
iding number of positive wells/plate/number of cells pla-
ted per well in irradiation group by number of positive
wells/plate/number of cells plated per well in control
plates. At least three plates were used for each group.
Cells were irradiated with singles doses of 0 Gy, 1 Gy,
2 Gy, 3 Gy, 4 Gy, 5 Gy and 7 Gy. In such experiments,
an increasing number of cells plated for each increment
in radiation dose. Therefore, effect of cell number per
well on plating efficiency was evaluated. Plating densities
of 1-10 cell/weel were tested. Although number of wells
with colonies increased with higher cell density, platingefficiency was not effected by number of cells. When 10
cells/well were used all wells in this set of experiments
contained colonies.
Survival curves were based on number of positive
wells or colonies in each irradiated group as a fraction of
that in control group. Survival curves where calculated
using Sigma Plot 8.0. At least three experiments where
performed for each dose point.Cell cycle analyses
Cell cycle analyses were performed after 0 h, 6 h, 12 h,
24 h, 48 h and 7 days irradiation with 2 Gy and 7 Gy
using flow cytometry using Propidium-Iodid (PI)-stain-
ing as described elsewhere [14]. Data were collected by
using FACScan flow cytometry, and results were ana-
lyzed by using cellquest software (both from Becton
Dickenson). For each sample, 10000 events were col-
lected, and aggregated cells were gated out.Intracellular cytokine staining: pRb and p53
The retinoblastoma gene encodes a nuclear phosphopro-
tein which is expressed in most normal cells and acts as
a tumor suppressor. An underphophorylated form of Rb
binds to viral oncogene HPV-E7[3]. Clone G3-245 rec-
ognizes an epitope between amino acids 300-380 of the
human retinoblastoma protein (pp110-114 Rb).
Wildtype p53 formes specific complexes with several
viral oncogenes including HPV-E6 and plays a role as
checkpoint protein for DNA damage during G1/S-phase
of cell cycle[9]. Clone G59-12 recognize mutant and wild
type human, mouse and rat p53 suppressor protein.
The G3-245 or G59-12 and MOPC-21 FITC (a mouse
IgG1 isotype control) conjugates are matched and F/P ra-
tios determined experimentally by flow cytometric analysis.
Details of the procedure are described as follows:
Ethanol fixated cells were washed two times in cold
PBS then resuspended in Fixation/Permialisation solu-
tion Perm/WashTM BD (1x106 cell/ml) for 30 min at 4°C
and pelleted by centrifugation. Afterwards buffer was re-
moved and cells were washed two times in fresh Perm/
WashTM BD buffer. Thoroughly resuspended cells were
subjected to intracellular cytokine staining by incubating
in 100μl Perm/WashTM BD buffer containing 20μl of Flu-
orochrome-conjugated antibody Rb-ak (FITC Mouse Anti-
Human Retinoblastoma Anti-Body from Becton Dickinson,
BD-Set:# 556538 Clone G3-245) for 24h at 4°C temper-
ature in the dark. After washing with Perm/WashTM BD
cells were pelleted and resuspended cells in 0,5 ml Perm/
WashTM BD for flow cytometric analysis. The same pro-
cedure was performed for p53 staining using 20μl of
Fluorochrome-conjugated antibody p53-ak (FITC Mouse
Anti-Human p53 Anti-Body from Becton Dickinson,
Clone G59-12).
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Stained cells were analyzed using FACSCan flow cyto-
metry (BD) equipped with a air-cooled 488 nm argon-ion
laser. Data acquisition and analysis were performed using
FACSComp and CELLQuest (version 3.4) software. A to-
tal event of 10 000 cells were acquired for each sample.
Data were expressed as geometric mean fluorescence in-
tensity and as ratio between fluorescence emission of sam-
ple cells and that of isotypic control (P/N ratio; positive/
negative). In each case negative control were cells treated as
described above without Rb-ak staining or p53-ak staining.
Isotypic control were cells treated with isotype–matched
control of irrelevant specificity from FITC Mouse IgG1
Isotype control (BD-Set# 556538) instead of Rb-ak stain-
ing or p53-ak staining. Analyses were performed after 0 h
and 24 h irradiation with 2 Gy and 7 Gy.Results
Intact E2-gene leads to higher radiation sensitivity in
cervical cells
The E2 gene of S12 cells (passage 88 – 103) was disrupted
in the E2C region.W12 cells (passage 8 –14) with an intact
E2 gene showed a higher radiosensitivity with a radiation
enhancement factor of 1.5 (4 Gy) (Figure 1).Radiation Dose (Gy)

















Figure 1 Survival curves (Sigma Plot 8.0) of W12 cells (intact
E2-gene) compared to S12 cells (disrupted E2-gene). Legend 1:
Clonogenic survival was analyzed by using 96-well in vitro test. The
E2 gene of S12 cells (passage 88 – 103) was disrupted in the E2C
region. W12 cells (passage 8 –14) with an intact E2 gene showed a
higher radiosensitivity with a radiation enhancement factor of 1.5 (4 Gy).E2-gene alters cell cycle regulation after radiation
Compared to S12 cells, W12 cells (intact E2-gene) showed
a G2/M-block 6 h-24 h after irradiation with 2 Gy. 48 h
after 2 Gy irradiation W12 cells entered cell cycle again.
After irradiation with 7 Gy G2/M-block of W12 cells
lasted at least 72 h and resolved after 7 days. Figure 2
shows flow cytometric analysis of W12 cells 24 h after
irradiation with 0 Gy, 2 Gy and 7 Gy. In control group
64% of cells were in G1, 9% in S-phase and 28% in G2/
M-phase. After irradiation with 2 Gy the amount of cells
in G2/M-phase increased to 43% and after irradiation
with 7 Gy to 52%. In G1-phase were 49% and 40% , in S-
phase 8% and 7% after irradiation with 2 Gy and 7 Gy,
respectively.
S12 cells (disrupted E2-gene) showed no effect like
G2/M- or G1-block after irradiation with 2 Gy. S12 cells
showed a G2/M-block 12 h to 48 h after irradiation with
7 Gy. 72 h after treatment S12 cell entered cell cycle
again. Figure 3 shows flow cytomtric analysis of S12 cells
24 h after irradiation with 0 Gy, 2 Gy and 7 Gy. In the
control group 58% of cells were in G1, 14% in S-phase
and 27% in G2/M-phase. After irradiation with 2 Gy cell
distribution remained the same. After irradiation with 7
Gy 50% of cells were in G2/M-phase, 41% in G1-phase
and 9% in S-phase.
S12 cells developed aneuploidy 48 h after 7 Gy irradi-
ation (Figure 4). Both cell lines did not develop a G1-
block (Figure 2 and 3).
E2-status changes pRb-expression after irradiation, but
p53-expression is not altered
81% of S12 cells (disrupted E2-gene) were positive for
pRb-expression in the control group. 24 h after irradi-
ation with 2 Gy and 7 Gy pRb- labeled cells dropped
down to 2.3% and to 5%, respectively (Figure 5).
W12 cells (intact E2-gene) showed 80%, 77% and 80%
pRb-labeled cells after irradiation with 0 Gy, 2 Gy and
7 Gy, respectively (Figure 6).
There was no significant overexpression of p53 in both
cell lines and no change after irradiation with 2 Gy or 7 Gy.
Discussion
Reasons for an increased radiocurability of HPV-positive
tumors are not defined yet. Disruption of the viral E2-
gene has been shown to be associated with poor out-
come in patients with cervical cancer [4,7,8]. Not only in
cervical cancer, but also in HPV-positive head and neck
cancer E2-protein may be relevant for treatment success
[15]. There is still a debate about direct influence of HPV
on radiosensitivity. Because for these clinical reports and
the referred interference of E2-protein with regulation of
apoptosis and cell cycle control [6,16] we established the
W12/S12 cell system to analyze influence of E2-gene status







Figure 2 Plot of flow cytometry using PI-staining for cell cycle
analysis of W12 cells (intact E2-gene). Legend 2: A = control
group, B = 2 Gy (24 h), C = 7 Gy (24 h): Figure 2 shows flow
cytometric analysis of W12 cells 24 h after irradiation with 0 Gy, 2 Gy
and 7 Gy. In control group 64% of cells were in G1, 9% in S-phase
and 28% in G2/M-phase. After irradiation with 2 Gy the amount of
cells in G2/M-phase increased to 43% and after irradiation with 7 Gy
to 52%. In G1-phase were 49% and 40% , in S-phase 8% and 7%
after irradiation with 2 Gy and 7 Gy, respectively.
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E2-gene [11,12]. We could demonstrate that a disrupted
E2-gene leads to radioresistance, because W12/S12 cells
differ only in E2-gene status, molecular tumor back-
ground is identical. Inactivation of normal function of
tumor suppressor proteins pRb and p53 are important
steps in human cervical carcinogenesis. Mutations of tu-
mor suppressor genes are rare in HPV-positive cervical
cancer cells [17]. The loss of the E2-gene causes reduced
proapoptotic signals, as well as deregulation of expres-
sion of the oncogenes E6 and E7 [18]. In response to
DNA-damaging, p53-levels increase by a posttranscrip-
tional mechanism resulting in arrest via inhibition of
cyclin-associated kinase activity at G1/S interface of cell
cycle [19]. Loss of p53 or expression of mutant p53
results in failure to arrest G1 [20,21]. E6 facilitates deg-
radation of p53 through its association with an accessory
protein E6-AP, a component of ubiquitin proteolytic
pathway [17,22,23]. In both cells types we could not de-
tect a G1-arrest, furthermore there was no significant ex-
pression of p53 in both cell types detectable. HPV E6
seems to inhibit p53 effectively independently of expres-
sion of E2. Pang et al. investigated the effect of E6 and its
isoforms on radiosensitivity by transfecting oral squamous
cell carcinoma cells with p53 mutations. They found a
radiosensitizing effect induced by E6. E6 also induced a
G1-cells loss and increased apoptosis [24]. We could not
demonstrate these effects in both cells types. Liu et al.
found also a radiosensitizing effect of E6 [25], but others
have reported opposite effect or no effect in keratinocytes
and other cell types exposed to ionizing radiation [26-29].
We found a difference in cell cycle regulation regard-
ing G2/M checkpoint. Cells with an intact E2-gene
showed a G2/M-block after irradiation with 2 Gy, but
cells with a disrupted E2-gene needed higher doses to
induce a G2/M-block. This suggests that in cells with an
intact E2-gene expression of functional p53 after DNA-
damage is dose dependent, because p53 is required for
sustaining G2/M-arrest [30]. Data showed that a given
dose of radiation induces a longer G2/M-delay in radio-
sensitive cell lines than in matched normal or resistant
cells [31]. This studies confirm our findings of S12 cells
entering cell cycle after 72 h, whereas W12 cells re-




Figure 3 Plot of flow cytometry using PI-staining for cell cycle
analysis of S12 cells (disrupted E2-gene). Legend 3: A = control
group, B = 2 Gy (24 h), C = 7 Gy (24 h): Figure 3 shows flow
cytomtric analysis of S12 cells 24 h after irradiation with 0 Gy, 2 Gy
and 7 Gy. In the control group 58% of cells were in G1, 14% in
S-phase and 27% in G2/M-phase. After irradiation with 2 Gy cell
distribution remained the same. After irradiation with 7 Gy 50% of
cells were in G2/M-phase, 41% in G1-phase and 9% in S-phase.
Lindel et al. Radiation Oncology 2012, 7:187 Page 5 of 8
http://www.ro-journal.com/content/7/1/187cells with a disrupted E2-gene developed aneuploidy af-
ter irradiation but cells with an intact E2-gene did not.
Liu et al. demonstrated that E6 is capable of inducing
DNA replication after postmitotic checkpoint arrest and
induces polyploidy independent of p53 [32]. P53 plays a
key role in mediating postmitotic checkpoint and be-
cause E6 targets p53 for degradation, E6 induces poly-
ploidy through inactivation of p53 [33,34]. Because we
could not find aneuploidy in cells with intact E2-gene
our experiments indicate that E2-status influences effect
of E6 on inducing aneuploidy and is triggered by irra-
diation. Experiments by Liu et al. showed amount of
cells undergoing apoptosis was inversely correlated with
polyploidy, suggesting that polyploid cells were subjected
to undergo apoptotic elimination and E6 can inhibit
polyploidy-associated apoptosis [32]. Radioresistence
may be related to aneuploidy and inhibition of apoptosis
by E6 in E2-disrupted cells.
We found down-regulation of pRb in cells with dis-
rupted E2-gene after irradiation with 2 and 7 Gy. As
previously shown, E7 oncoprotein binds to hypopho-
sphorylated pRb form resulting in its degradation and
inappropriate release of E2F transcription factor [10]. De-
crease of pRb is therefore an indirect sign of an increased
expression of E7 after irradiation dependent on E2-geneFigure 4 Plot of flow cytometry using PI-staining: S12 cells
(disrupted E2-gene) developed aneuploidy 48 h after





Figure 5 Plot of flow cytometry using intracellular staining: No
change of pRB labeling in W12 cells (intact E2-gene) after
irradiation. Legend 5: A = control group, B = 2 Gy, C = 7 Gy: In
each case negative control were cells treated as described above
without Rb-ak staining. Isotypic control were cells treated with
isotype–matched control of irrelevant specificity from FITC Mouse
IgG1 Isotype control (BD-Set# 556538) instead of Rb-ak staining or
p53-ak staining. Analyses were performed after 0 h and 24 h
irradiation with 2 Gy and 7 Gy.W12 cells (intact E2-gene) showed
80%, 77% and 80% pRb-labeled cells after irradiation with 0 Gy,






Figure 6 Plot of flow cytometry using intracellular staining:
Change of pRB labeling in S12 cells (disrupted E2-gene) after
irradiation. Legend 6: A = control group, B = 2 Gy, C = 7 Gy: 81%
of S12 cells (disrupted E2-gene) were positive for pRb-expression in
the control group. 24 h after irradiation with 2 Gy and 7 Gy pRb-
labeled cells dropped down to 2.3% and to 5%, respectively.
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(12.5-100 Gy) could increase E6/E7 expression in cervical
carcinoma cell lines [35]. Our experiments indicate that
disrupted E2-gene in HPV positive cells lead to an over-
expression of the oncogene E7 with a down-regulation of
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tion of pRb with cidofivor leads to increased radiosensitiv-
ity [36]. DeWeese et al. found low dose rate radiotherapy
led to both G1 and G2 arrest expressing E6, but in cells
expressing both E6 and E7, cells arrested only in G2.
Despite this difference cell cycle arrest, no difference in
clonogenic survival was seen [28]. Gammoh et al. could
demonstrate that activity of E7 can be controlled through
a direct interaction with E2, resulting in an inhibition of
the activity of E7[37] and that E7-induced degradation of
pRb was rescued [38].
Our experiments confirm lack of G1-arrest independ-
ent of E2-gene status. The up-regulation of E7 reducing
functional pRb seems to be an essential factor for en-
hanced radioresistance of cells with a disrupted E2-gene.
Conclusion
Our experiment support the hypothesis that better prog-
nosis of patients with E2-gene positive cervical cancer is
determined by a better response to radiotherapy com-
pared to HPV-positive cancers without an intact E2-gene.
Not only differences in cell cycle regulation, but also reg-
ulation of expression of E7 might contribute to E2-
dependent radioresponse.
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